Adjuvant chemotherapy for adult soft tissue sarcomas of the extremities and girdles: Results of the italian randomized cooperative trial

Journal of Clinical Oncology

Volumn 19, Issue 5, 2001, Pages 1238-1247

  Frustaci, S ^a   Gherlinzoni, F ^a   De Paoli, A ^a   Bonetti, M ^a   Azzarelli, A ^a   Comandone, A ^a   Olmi, P ^a   Buonadonna, A ^a   Pignatti, G ^a   Barbieri, E ^a   Apice, G ^a   Zmerly, H ^a   Serraino, D ^a   Picci, P ^a  

^a CENTRO DI RIFERIMENTO ONCOLOGICO   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

EPIRUBICIN; GRANULOCYTE COLONY STIMULATING FACTOR; IFOSFAMIDE; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR;

ADJUVANT CHEMOTHERAPY; ADULT; AGED; ARTICLE; CANCER GRADING; CANCER RECURRENCE; CANCER SURVIVAL; CLINICAL ARTICLE; CONTROLLED STUDY; FOLLOW UP; HIGH RISK POPULATION; HUMAN; HYDRATION; ITALY; PRIORITY JOURNAL; SHOULDER GIRDLE; SOFT TISSUE SARCOMA; SURVIVAL TIME; TREATMENT PLANNING; TUMOR RECURRENCE; TUMOR VOLUME;

EID: 0035282058     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2001.19.5.1238     Document Type: Article

References (36)

1. General considerations
2. The epidemiology of soft tissue sarcomas
3. Comparative study of the National Cancer Institute and French Federation of Cancer Centers Sarcoma Group grading systems in a population of 410 adult patients with soft tissue sarcoma
4. Tumors of the connective and supporting tissues. (Regaud Lecture, Granada 1994)
5. Prognostic factors for local control of sarcomas of the soft tissues managed by radiation and surgery
6. Future directions in the management of soft tissue sarcomas
7. Sarcoma Metanalysis Collaboration: Adjuvant chemotherapy for localised resectable soft-tissue sarcoma: Meta-analysis of individual data
8. Preliminary results of an adjuvant randomized trial on high risk extremity soft tissue sarcomas (STS): The interim analysis
9. Association of local recurrence with subsequent survival in extremity soft tissue sarcoma
10. Grading of soft tissue sarcomas: Experience of the EORTC soft tissue and bone sarcoma group
11. Non parametric estimation from incomplete observations
12. Regression models and life-tables (with discussion)
13. A class of K-sample tests for comparing the cumulative incidence of a competing risk
14. Prospective randomized evaluation of adjuvant chemotherapy in adults with soft tissue sarcomas of the extremities
15. Prospective randomized trials demonstrating the efficacy of adjuvant chemotherapy in adult patients with soft tissue sarcomas
16. A randomized trial for the treatment of high-grade soft-tissue sarcomas of the extremities: Preliminary observations
17. Results of a randomized trial for the treatment of localized soft tissue tumors (STS) of the extremities in adult patients
18. Adjuvant chemotherapy with CyVADIC in high-risk soft tissue sarcoma: A randomized prospective trial
19. National Cancer Institute experience in the management of high-grade extremity soft tissue sarcoma
20. Late results of a randomized trial for the treatment of soft tissue sarcomas (STS) of the extremities in adult patients
21. Adjuvant therapy of sarcomas of soft tissue
22. Pooled results from three randomized adjuvant studies of doxorubicin versus observation in soft tissue sarcoma: 10-year results and review of the literature
23. Studies on the urotoxicity of oxazaphosphorine cytostatics and its prevention, III. Profile of action of sodium 2-mercaptoethane sulfonate (mesna)
24. Ifosfamide
25. Cyclophosphamide vs ifosfamide: Final report of a randomized phase II trial in adult soft tissue sarcomas
26. Increasing 4′-epidoxorubicin and fixed ifosfamide doses plus granulocyte-macrophage colony-stimulating factor in advanced soft tissue sarcomas: A pilot study
27. Ifosfamide plus epirubicin at escalating doses in the treatment of locally advanced and/or metastatic sarcomas
28. Granulocyte-macrophage colony-stimulating factor allows safe escalation of dose-intensity of chemotherapy in metastatic adult soft tissue sarcomas: A study of the European Organisation for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group
29. Dose-intensive chemotherapy with ifosfamide, epirubicin, and filgrastim for adult patients with metastatic or locally advanced soft tissue sarcoma: A phase II study
30. Epirubicin ifosfamide in advanced soft tissue sarcomas
31. Preoperative irradiation for soft tissue sarcomas of the trunk and extremities in adults
32. Preoperative radiation, surgical margins and local control of extremity sarcomas of soft tissues
33. Adjuvant CYVADIC chemotherapy for adult soft tissue sarcoma reduced local recurrence but no improvement in survival: A study of the European Organization for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group
34. Evidence for using adjuvant chemotherapy as standard treatment of soft tissue sarcoma
35. The reason for confining the use of adjuvant chemotherapy in soft tissue sarcoma to the investigational setting